MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--TYRX, Inc., the leader in the commercialization of implantable medical devices designed to help reduce surgical-site infections associated with cardiovascular implantable electronic devices (CIEDs) including pacemakers and implantable defibrillators, announced today that Frost & Sullivan has named the AIGISRx® Antibacterial Envelope as the recipient of its prestigious New Product Innovation Award for 2012.
